Of note, ADAMTS13 activity testing is labor intensive and not readily available at most institutions—meaning plasma exchange should be administered if TTP is reasonably suspected given its high mortality without treatment [8]. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.